Presentation Information

[28-20-pm06S]Establishing novel molecular-targeted therapy based on the tumor suppressor gene CYLD to overcome cross-resistance between chemotherapy and radiotherapy

○Kou Yonemaru1, Naoki Suenaga1,2, Ayumi Kanemaru1,3, Hideyuki Saito1,4, Hirofumi Jono1,4 (1. Department of Clinical Pharmaceutical Sciences, Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Gofuku Pharm., 3. Clinical Research, Innovation and Education Center, Tohoku Univ. Hospital, 4. Department of Pharmacy, Kumamoto Univ. Hospital)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.